|Day Low/High||155.60 / 159.72|
|52 Wk Low/High||128.58 / 163.75|
The FDA approved 11 different hematological treatments this year after approving 11 in the previous two years combined.
Vyxeos granted accelerated assessment review status from European Medicines Agency's Committee for Medicinal Products for Human Use
The firm received a "refusal to file letter" from the FDA regarding the new drug application for Inbrija, a potential treatment for Parkinson's disease.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and ImmunoGen, Inc. (Nasdaq: IMGN) today announced that the companies have entered into a collaboration and option agreement granting Jazz Pharmaceuticals exclusive, worldwide rights...
Strengthens Jazz hematology/oncology portfolio with options for innovative development candidates IMGN779 and IMGN632
The Dublin firm announced an offering of $500 million of exchangeable senior notes due 2024.
Vyxeos represents the first new chemotherapy advance in more than 40 years for these adults with AML
David Hung will become Axovant's CEO after completing the $14 billion sale of Medivation to Pfizer.
Positive phase three data was a boon for Trevena, but Synergy's "Poop Troop" put pressure on its stock.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ACSF, CAA, JAZZ, LFL, MTH, SUM, WYNN Downgrades: REV, TROW, WAGE Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.